Amphetamine salts shortage?

Short answer: there have been shortages of amphetamine-salt ADHD meds (like Adderall and generic mixed amphetamine salts) at various times in the US and other markets. Availability can vary by brand, dosage, and location, and it’s not guaranteed to be in stock every day.

What you can do if you’re dealing with a shortage
- Talk to your pharmacist and prescribing clinician about options:
- Try a different brand or an alternative amphetamine product (e.g., a different release formulation or a different salt combination).
- Consider a non-amphetamine stimulant or a non-stimulant option if appropriate (see below).
- If you’re stable on a specific dose, ask if a temporary alternative can be used and what monitoring is needed.
- Ask about dosage and formulation changes carefully:
- Some people tolerate switching from IR to XR or from one brand to another with minimal changes; others may need dose adjustments.
- Clarify how the switch might affect onset and duration of effect.
- Check practical options:
- See if a 30- or 60-day supply is possible to bridge a shortage (often requires insurer/doctor authorization).
- Look into manufacturer updates or patient-informational notices from the FDA and the药厂 (pharmacy) for current status.
- If available stock is consistently low, your clinician might consider:
- Lisdexamfetamine (Vyvanse) or other non-amphetamine stimulants (e.g., methylphenidate formulations) as alternatives.
- Non-stimulant options if stimulants aren’t feasible or tolerated (atomoxetine, guanfacine, clonidine), though they have different efficacy and side-effect profiles.

Safety notes
- Amphetamine products are Schedule II controlled substances; don’t attempt to stockpile or obtain from unregulated sources.
- Do not change or stop your medication abruptly without medical advice, as withdrawal or rebound symptoms can occur.

If you’d like, tell me your country/region and the exact medication and dose you’re asking about (e.g., Adderall 20 mg IR, 30 mg XR, etc.). I can tailor the guidance and point you to the most relevant and recent general information sources (like FDA drug-shortages pages and common alternatives).